Tischler M D, Niggel J B, Battle R W, Fairbank J T, Brown K A
Department of Medicine, University of Vermont, College of Medicine, Burlington 05401.
J Am Coll Cardiol. 1994 Jan;23(1):141-5. doi: 10.1016/0735-1097(94)90512-6.
The purpose of this study was to test the hypothesis that segmental wall motion analysis determined from gated planar technetium-99m sestamibi myocardial imaging is reproducible and agrees well with echocardiographic data.
Technetium-99m sestamibi is a new radiopharmaceutical recently approved for myocardial perfusion imaging. Its advantages include a dosimetry that allows use of a dose 10 to 15 times higher than that of thallium-201. As a result, myocardial counts are markedly improved and images can be collected in a gated mode to potentially allow assessment of global and segmental ventricular function. However, the reproducibility and accuracy of technetium-99m sestamibi imaging for measurement of global and segmental left ventricular function have not been evaluated or compared with those of a standard ventricular function technique, such as echocardiography.
We studied 136 patients referred for clinical technetium-99m sestamibi imaging. One-day rest-stress planar technetium-99m sestamibi protocols were used, gating the stress images. After technetium-99m sestamibi imaging, all patients had standard rest two-dimensional echocardiography. Global and segmental technetium-99m sestamibi and echocardiographic left ventricular contraction was graded qualitatively as normal or abnormal using a four-point grading system.
Interobserver and intraobserver agreement was extremely high for global and segmental technetium-99m sestamibi wall motion analysis, with absolute agreements ranging from 0.92 to 1.00 and corresponding kappa values of 0.74 to 1.00 (p < 0.00001). Agreement with global and segmental echocardiographic wall motion was similarly very high, with absolute agreements ranging from 0.93 to 1.00 and corresponding kappa values of 0.75 to 1.00 (p < 0.00001).
Gated technetium-99m sestamibi cardiac imaging provides information with regard to rest global and segmental left ventricular systolic function that is highly reproducible and agrees very well with results of two-dimensional echocardiography.
本研究旨在验证以下假设,即通过门控平面锝-99m 甲氧基异丁基异腈心肌显像确定的节段性室壁运动分析具有可重复性,且与超声心动图数据高度吻合。
锝-99m 甲氧基异丁基异腈是一种最近被批准用于心肌灌注显像的新型放射性药物。其优点包括剂量测定允许使用比铊-201高10至15倍的剂量。因此,心肌计数显著提高,并且可以以门控模式采集图像,从而有可能评估整体和节段性心室功能。然而,锝-99m 甲氧基异丁基异腈显像用于测量整体和节段性左心室功能的可重复性和准确性尚未得到评估,也未与标准心室功能技术(如超声心动图)进行比较。
我们研究了136例因临床需要进行锝-99m 甲氧基异丁基异腈显像的患者。采用一日静息-负荷平面锝-99m 甲氧基异丁基异腈方案,对负荷图像进行门控。在锝-99m 甲氧基异丁基异腈显像后,所有患者均接受标准静息二维超声心动图检查。使用四点分级系统将整体和节段性锝-99m 甲氧基异丁基异腈及超声心动图左心室收缩定性分为正常或异常。
对于整体和节段性锝-99m 甲氧基异丁基异腈室壁运动分析,观察者间和观察者内的一致性极高,绝对一致性范围为0.92至1.00,相应的kappa值为0.74至1.00(p < 0.00001)。与整体和节段性超声心动图室壁运动的一致性同样非常高,绝对一致性范围为0.93至1.00,相应的kappa值为0.75至1.00(p < 0.00001)。
门控锝-99m 甲氧基异丁基异腈心脏显像提供了关于静息状态下整体和节段性左心室收缩功能的信息,该信息具有高度可重复性,且与二维超声心动图结果高度吻合。